Recombinant Human CXCL6 Protein，His

CXCL6, also known as CXC chemokine ligand 6 or Gro-α, is a member of the CXC chemokine family that plays a crucial role in the immune response and inflammation. It is primarily produced by various cell types, including macrophages, fibroblasts, and endothelial cells, in response to pro-inflammatory stimuli. CXCL6 exhibits potent chemotactic properties, attracting neutrophils and other immune cells to sites of tissue injury or infection, thus participating in host defense mechanisms. Research has shown that CXCL6 is involved in various pathological conditions, including cancer, autoimmune diseases, and chronic inflammatory disorders. Its expression levels are often elevated in tumors, where it contributes to tumor progression, metastasis, and the creation of an immunosuppressive microenvironment. To further understand its biologic functions and therapeutic potential, the development of recombinant CXCL6 protein for in vitro and in vivo studies has gained significant interest. This recombinant protein can be used to explore the mechanisms by which CXCL6 influences immune cell behavior, its role in disease processes, and potential applications in targeted therapies. Understanding CXCL6's interactions and signaling pathways could pave the way for novel therapeutic strategies aimed at modulating immune responses and improving outcomes in diseases characterized by dysregulated inflammation or immune evasion.